We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

EUS-CPN: A Retrospective Review

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00577564
First Posted: December 20, 2007
Last Update Posted: September 12, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Indiana University
  Purpose
The purpose of this retrospective study is to measure the safety of EUS-CPN in patients that have undergone this procedure in the last decade.

Condition
Pancreatic Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN): A Retrospective Review of Safety

Resource links provided by NLM:


Further study details as provided by Indiana University:

Primary Outcome Measures:
  • Number of EUS-CPN procedures for each patient [ Time Frame: over a ten year period ]

Secondary Outcome Measures:
  • Procedure-related complications [ Time Frame: over a ten year period ]

Study Start Date: July 2006
Study Completion Date: December 2007
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients that underwent a EUS-CPN over a ten year period at Indiana University Medical Center will be considered.
Criteria

Inclusion Criteria:

  • Any subject that has undergone EUS-CPN will be considered for this study.

Exclusion Criteria:

  • Subjects will be excluded if they have undergone a celiac plexus neurolysis (endoscopic, percutaneous, or surgical) at an another institution.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00577564


Locations
United States, Indiana
Clarian: University Hospital
Indianpolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
Investigators
Principal Investigator: Julia LeBlanc, MD, MPH Indiana University School of Medicine
  More Information

Responsible Party: Dr. Julia LeBlanc, Indiana University Medical Center
ClinicalTrials.gov Identifier: NCT00577564     History of Changes
Other Study ID Numbers: 0606-59
IRB #0606-59
First Submitted: December 19, 2007
First Posted: December 20, 2007
Last Update Posted: September 12, 2012
Last Verified: September 2012

Additional relevant MeSH terms:
Pancreatic Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Endocrine Gland Neoplasms
Digestive System Diseases
Pancreatic Diseases
Endocrine System Diseases